Literature DB >> 22447980

Molecular mechanisms in the dramatic enhancement of HIV-1 Tat transduction by cationic liposomes.

Guan-Han Li1, Wenxue Li, Russell J Mumper, Avindra Nath.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) transactivator of transcription (Tat) protein possesses a unique membrane-transduction property. Interestingly, Tat transduction could be dramatically increased 1000-fold based on LTR-transactivation assay when complexed with cationic liposomes (lipo-Tat), compared with Tat alone. Therefore, underlining mechanisms were explored further. Microscopy and flow cytometry showed that this effect was associated with enhanced membrane binding, large particle formation (1-2 μm) and increased intracellular uptake of Tat fluorescent proteins. Using pharmacological assays and immune colocalizations, it was found that lipid raft-dependent endocytosis and macropinocytosis were major pathways involved in lipo-Tat uptake, and actin-filaments played a major role in intracellular trafficking of lipo-Tat to the nucleus. Furthermore, we found that the Tat hydrophobic domain (aa 36-47) mediated formation of two positively charged molecules into lipo-Tat complexes via hydrophobic bonds, based on LTR-transactivation inhibition assay. Thus, the hydrophobic domain may play an important role in Tat protein uptake and be useful for intracellular delivery of biomacromolecules if coupled together with Tat basic peptide, a cell-penetrating peptide.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447980      PMCID: PMC3382090          DOI: 10.1096/fj.11-203315

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  73 in total

1.  Cationic liposome-mediated uptake of human immunodeficiency virus type 1 Tat protein into cells.

Authors:  S E Fong; P Smanik; M C Smith; S R Jaskunas
Journal:  J Virol Methods       Date:  1997-06       Impact factor: 2.014

2.  HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region.

Authors:  H C Chang; F Samaniego; B C Nair; L Buonaguro; B Ensoli
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

3.  Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells.

Authors:  M Ma; A Nath
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 4.  Control of RNA initiation and elongation at the HIV-1 promoter.

Authors:  K A Jones; B M Peterlin
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

5.  Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Authors:  E J Platt; K Wehrly; S E Kuhmann; B Chesebro; D Kabat
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer.

Authors:  H Farhood; N Serbina; L Huang
Journal:  Biochim Biophys Acta       Date:  1995-05-04

7.  Visualizing a specific contact in the HIV-1 Tat protein fragment and trans-activation responsive region RNA complex by photocross-linking.

Authors:  Y Liu; Z Wang; T M Rana
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

8.  Intracellular trafficking and interactions of the HIV-1 Tat protein.

Authors:  R H Stauber; G N Pavlakis
Journal:  Virology       Date:  1998-12-05       Impact factor: 3.616

9.  Endosomolytic activity of cationic liposomes enhances the delivery of human immunodeficiency virus-1 trans-activator protein (TAT) to mammalian cells.

Authors:  L Huang; H Farhood; N Serbina; A G Teepe; J Barsoum
Journal:  Biochem Biophys Res Commun       Date:  1995-12-26       Impact factor: 3.575

10.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.

Authors:  B Ensoli; L Buonaguro; G Barillari; V Fiorelli; R Gendelman; R A Morgan; P Wingfield; R C Gallo
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more
  11 in total

1.  AU4S: a novel synthetic peptide to measure the activity of ATG4 in living cells.

Authors:  Zhenhong Ni; Yi Gong; Xufang Dai; Wen Ding; Bin Wang; Haiyan Gong; Liyan Qin; Panke Cheng; Song Li; Jiqin Lian; Fengtian He
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

2.  Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.

Authors:  Pejman Rahimian; Johnny J He
Journal:  J Neurovirol       Date:  2016-05-12       Impact factor: 2.643

3.  HIV-1C and HIV-1B Tat protein polymorphism in Southern Brazil.

Authors:  Sérgio Monteiro de Almeida; Indianara Rotta; Luine Rosele Renaud Vidal; Jucelia Stadinicki Dos Santos; Avindra Nath; Kory Johnson; Scott Letendre; Ronald J Ellis
Journal:  J Neurovirol       Date:  2021-01-18       Impact factor: 2.643

Review 4.  Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.

Authors:  Hua Li; Tung Yu Tsui; Wenxue Ma
Journal:  Int J Mol Sci       Date:  2015-08-18       Impact factor: 5.923

Review 5.  Rationale and Methodology of Reprogramming for Generation of Induced Pluripotent Stem Cells and Induced Neural Progenitor Cells.

Authors:  Zuojun Tian; Fuzheng Guo; Sangita Biswas; Wenbin Deng
Journal:  Int J Mol Sci       Date:  2016-04-20       Impact factor: 5.923

6.  HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity.

Authors:  Alina Hategan; Mario A Bianchet; Joseph Steiner; Elena Karnaukhova; Eliezer Masliah; Adam Fields; Myoung-Hwa Lee; Alex M Dickens; Norman Haughey; Emilios K Dimitriadis; Avindra Nath
Journal:  Nat Struct Mol Biol       Date:  2017-02-20       Impact factor: 15.369

Review 7.  Proteins reprogramming: present and future.

Authors:  Yang Yang; Bin Liu; Jianwen Dong; Liangming Zhang; Mao Pang; Limin Rong
Journal:  ScientificWorldJournal       Date:  2012-11-22

8.  Productive HIV infection in astrocytes can be established via a nonclassical mechanism.

Authors:  Guan-Han Li; Dragan Maric; Eugene O Major; Avindra Nath
Journal:  AIDS       Date:  2020-06-01       Impact factor: 4.632

9.  Enhanced cellular entry and efficacy of tat conjugates by rational design of the auxiliary segment.

Authors:  Pengcheng Zhang; Lye Lin Lock; Andrew G Cheetham; Honggang Cui
Journal:  Mol Pharm       Date:  2014-01-29       Impact factor: 4.939

10.  Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation.

Authors:  Nabab Khan; Gaurav Datta; Jonathan D Geiger; Xuesong Chen
Journal:  J Neuroinflammation       Date:  2018-03-20       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.